This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of The Spanner Prostatic Stent (SRS Medical) for primary treatment of male bladder outlet obstruction for urinary function, symptom relief, and quality of life improvement.
Evolving Evidence Reviews
Evolving Evidence Reviews are designed to help clients develop policies and manage prior authorizations. Evolving Evidence Reviews are useful when a technology moves beyond emerging but the literature is not mature enough for a full Health Technology Assessment. Evolving Evidence Reviews provide a full-text appraisal of clinical studies, systematic reviews, and clinical practice guidelines as they relate to a specific health technology. Evolving Evidence Reviews provide Levels of Support indicated by these types of evidence. They also provide information on regulatory status, payer policies, and Hayes Insights.
Minimally Invasive Posterior Sacroiliac Joint Fusion Using a Bone Allograft for Management of Sacroiliac Joint Pain
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of minimally invasive posterior sacroiliac joint (SIJ) fusion using engineered bone allografts placed within the SIJ for management of chronic SIJ pain.
Prolastin-C (Grifols Therapeutics Inc.) Compared With Other Augmentation Therapies for Management of Patients With Alpha-1 Antitrypsin Deficiency and Lung Disease
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of alpha-1 antitrypsin (AAT) augmentation therapy with Prolastin or Prolastin-C over other alpha-1 proteinase inhibitors (A1PIs), for management of lung disease in patients with AAT deficiency (AATD).
Vowst (Fecal Microbiota Spores, Live-brpk; Seres Therapeutics Inc.) for Prevention of Recurrent Clostridioides Difficile Infection
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of Vowst (fecal microbiota spores, live-brpk; formerly SER-109) for prevention of recurrent Clostridioides difficile infection (rCDI).
Rebyota (Fecal Microbiota, Live-jslm) for Prevention of Recurrent Clostridioides Difficile Infection
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of Rebyota (fecal microbiota, live-jslm) for prevention of recurrent Clostridioides difficile infection (rCDI).
ApiFix (ApiFix Ltd.) for Treatment of Adolescent Idiopathic Scoliosis
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of the currently available design of the ApiFix (ApiFix Ltd.) minimally invasive deformity correction system for spinal curvature correction in the treatment of adolescent idiopathic scoliosis.
Kerecis Omega3 Wound (Kerecis) Fish Skin Grafts for the Management of Diabetic Foot Ulcers
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of Kerecis Omega3 Wound fish skin grafts for improving healing and closure of diabetic foot ulcers (DFUs).
Kerecis Omega3 Wound (Kerecis) Fish Skin Grafts for Management of Burns
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of Kerecis Omega3 Wound (Kerecis) fish skin grafts for treatment of burns.
Platelet-Rich Plasma for Treatment of Patellar Tendinopathy
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of platelet-rich plasma for treatment of patellar tendinopathy.
NovoSorb Biodegradable Temporizing Matrix (BTM) (PolyNovo Pty Ltd.) for Treatment of Diabetic Foot Ulcers
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of NovoSorb Biodegradable Temporizing Matrix (BTM) (PolyNovo Pty Ltd.) for treatment of diabetic foot ulcers (DFUs).